Indications
Active immunisation of cats aged 8 weeks and older: against feline viral rhinotracheitis to reduce clinical signs; against calicivirus infection to reduce clinical signs and excretion; against Chlamydophila felis infection to reduce clinical signs. Onsets of immunity have been demonstrated 1 week after primary vaccination course for rhinotracheitis, calicivirus and Chlamydophila felis components. The duration of immunity is 1 year after the last (re-)vaccination.
Composition
- Active substance
- attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline calicivirosis antigens (FCV 431 and G1 strains), attenuated Chlamydophila felis (905 strain)
- International name (INN)
- vaccine against feline viral rhinotracheitis, feline calicivirosis and feline Chlamydophila infections
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Purevax RCCh
- Group
- Veterinary medicines